In a statement, Philips said it does not admit any wrongdoing but chose to settle "to end the uncertainty associated with ...

Philips Respironics announced that it agreed to pay over a billion dollars to settle claims stemming from the 2021 U.S.

It's possible that the interrupted breathing and lowered oxygen levels of apnea might be harming the brain It's not yet known ...

It is important to note that we do not need to snore or snore loudly to have sleep apnea. Unfortunately, many healthcare ...

A new clinical trial from drugmaker Eli Lilly shows that Zepbound and Mounjaro reduced obstructive sleep apnea symptoms.

The U.S. Food and Drug Administration (FDA) approved Zepbound for the treatment of obesity in November 2023. Some prescribe ...

Sleep apnea and late-midlife oxygen desaturation to less than 80 percent during sleep are associated with subsequent development of late-onset epilepsy (LOE), according to a study recently published ...

Dutch manufacturer Philips has agreed to pay $1.1 billion to settle lawsuits regarding some models of its devices to treat ...

Findings provide further insight into the complex relationship between sleep disorders and epilepsy ...

Dutch medical device maker Philips says it's reached a $1.1 billion deal in the United States to settle lawsuits over faulty ...

Eli Lilly reported its phase 3 clinical trial data that showed showed significant reduction in sleep apnea symptoms in people ...

Tirzepatide, the active ingredient in Mounjaro and Zepbound, reduced sleep apnea symptoms in people with obesity, whether or ...